Evvy launches AI advisor built on vaginal microbiome data

Uses data from more than 100,000 tests

Precision women’s health company Evvy has launched “EvvyAI”, an AI-powered advisor designed to help women interpret vaginal microbiome results and navigate questions around vaginal health, fertility and menopause.

The tool is built on data from more than 100,000 vaginal microbiome tests, which the company says makes it one of the largest datasets of its kind focused specifically on female biology. Users can ask questions through a conversational interface designed to explain test results, provide research-backed guidance and surface relevant educational information.

The launch reflects a broader shift emerging across women’s health as companies are no longer just offering testing or diagnostics, but increasingly positioning themselves as the interpretation layer sitting between data and clinical care.

“For too long, women have been left to navigate their own health in the dark - searching the internet, second-guessing themselves, and getting answers that weren't built for their bodies,” said Priyanka Jain, co-founder and CEO of Evvy.

“EvvyAI provides access to real science - based entirely on the female body - to every woman who needs it.”

The interpretation gap

As at-home diagnostics, wearables and health tracking tools proliferate, many users are left managing large amounts of fragmented health information without clear clinical support. AI is increasingly being framed as the solution to that “interpretation gap” - helping users contextualise results, identify patterns and stay engaged between appointments.

Women’s health may be particularly suited to this model given the longitudinal nature of care across areas including fertility, menopause, hormones and chronic vaginal health, where patients often spend years navigating symptoms and conflicting advice.

Evvy’s launch also lands amid growing scrutiny around the reliability of AI-generated healthcare advice, with a study last year finding that AI models currently fail on around 60% of women’s health questions due in part to historical underrepresentation of women in medical datasets.

Notably, Evvy says the platform is designed to recognise when human clinical support is required, directing users to Evvy’s care team where appropriate. Prescription care programmes and test results will continue to be reviewed by licensed clinicians.

The move follows a wider wave of AI-driven interpretation tools emerging across healthcare and women’s health specifically - from diagnostic explainers and symptom guidance to wearable-driven coaching and personalised care navigation - signalling that the next competitive layer may not simply be generating more health data, but helping users understand what to do with it.